_________
false
כיטוב פארמה בע"מ
2
352
KITOV PHARMA LTD
Corporation no:
520031238
12724
Israel Securities Authority
Tel Aviv Stock Exchange
C004
(
Public
)
Reported via MAGNA:
29/06/2020
www.isa.gov.il
www.tase.co.il
Reference:
2020-02-060454
Time of broadcast:
21:58
21:55:43
Complementary report for a report sent on date
25/06/2020
whose reference number was
2020-02-058657
Main details added/ completed:
Amends the initial submission of the Form 6-K to replace Form of Placement Agent Warrant included as Exhibit 4.2 in the initial submission to reflect the correct exercise price of $1.125 per ADS, instead of $0.90 as stated in the original exhibit
Immediate report on other matter
Don't use this form if there is more adequate one
תיקון לדיווח מיום 25.6.2020- מסמכים בקשר למכירת ני"ע של החברה שהוצעו במסגרת הנפקה פרטית
Attached file
ea123580-6ka1_kitovpharmaEDGAR1_Bannerless_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NASDAQ CM
Date of revision of form structure:
23/06/2020
Address:
Menachem Begin St, Azrieli Towers Round Tower
132
,
Tel Aviv
6701101
,
Israel
Tel:
03-9333121
,
Fax:
03-5097196
E-mail address:
info@kitovpharma.com
Company site:
www.kitovpharma.com
Previous names of reporting entity:
KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,
Name of the Signatory:
Masas Ludmer Adi
Position of Signatory in the reporting corporation:
Company Controller
Name of Employer Company:
Address:
Menachem Begin Drive
132
,
Tel Aviv
6701101
Telephone:
03-9333121
Facsimile:
03-5097196
E-mail:
adim@kitovpharma.com
1
Israel